Eqis Capital Management Inc. boosted its position in shares of CME Group Inc. (NASDAQ:CME) by 37.5% during the third quarter, HoldingsChannel reports. The institutional investor owned 2,657 shares of the financial services provider’s stock after purchasing an additional 724 shares during the period. Eqis Capital Management Inc.’s holdings in CME Group were worth $445,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Trustcore Financial Services LLC grew its stake in CME Group by 397.1% during the second quarter. Trustcore Financial Services LLC now owns 174 shares of the financial services provider’s stock worth $28,000 after buying an additional 139 shares in the last quarter. Tarbox Family Office Inc. grew its stake in CME Group by 75.5% during the third quarter. Tarbox Family Office Inc. now owns 193 shares of the financial services provider’s stock worth $32,000 after buying an additional 83 shares in the last quarter. Rockbridge Investment Management LCC boosted its stake in shares of CME Group by 1,663.6% in the 3rd quarter. Rockbridge Investment Management LCC now owns 194 shares of the financial services provider’s stock valued at $32,000 after purchasing an additional 183 shares in the last quarter. CVA Family Office LLC acquired a new stake in shares of CME Group in the 3rd quarter valued at approximately $38,000. Finally, Exchange Traded Concepts LLC acquired a new stake in shares of CME Group in the 3rd quarter valued at approximately $46,000. Hedge funds and other institutional investors own 75.78% of the company’s stock.
A number of research firms have recently weighed in on CME. Rosenblatt Securities reduced their price target on shares of CME Group from $141.00 to $139.00 and set a “sell” rating on the stock in a research note on Wednesday, November 4th. Credit Suisse Group lifted their target price on shares of CME Group from $170.00 to $177.00 and gave the stock a “neutral” rating in a research report on Thursday, September 10th. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating and set a $175.00 target price on the stock in a research report on Tuesday, September 29th. Loop Capital started coverage on shares of CME Group in a research report on Friday, September 11th. They set a “sell” rating and a $138.00 target price on the stock. Finally, Oppenheimer reiterated a “buy” rating on shares of CME Group in a research report on Wednesday, July 29th. Five equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the stock. CME Group currently has a consensus rating of “Hold” and an average target price of $183.35.
Shares of CME opened at $167.47 on Friday. The business’s 50-day moving average price is $162.70 and its 200-day moving average price is $170.00. CME Group Inc. has a twelve month low of $131.80 and a twelve month high of $225.36. The stock has a market cap of $60.12 billion, a PE ratio of 27.91, a P/E/G ratio of 12.68 and a beta of 0.37. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 28th. The financial services provider reported $1.38 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.41 by ($0.03). The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.09 billion. CME Group had a return on equity of 9.22% and a net margin of 43.68%. During the same quarter last year, the company posted $1.90 earnings per share. Analysts expect that CME Group Inc. will post 6.75 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Thursday, December 10th will be given a $0.85 dividend. This represents a $3.40 annualized dividend and a dividend yield of 2.03%. The ex-dividend date of this dividend is Wednesday, December 9th. CME Group’s dividend payout ratio (DPR) is 50.00%.
In other CME Group news, insider Ken Vroman sold 4,541 shares of the company’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $152.63, for a total value of $693,092.83. Following the completion of the sale, the insider now owns 9,879 shares of the company’s stock, valued at $1,507,831.77. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Dennis Suskind sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $174.61, for a total value of $349,220.00. Following the completion of the sale, the director now directly owns 3,565 shares of the company’s stock, valued at approximately $622,484.65. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,541 shares of company stock worth $1,909,913. 1.20% of the stock is owned by company insiders.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.
Read More: Hedge Funds – Risk or Reward?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.